Details of the Drug

General Information of Drug (ID: DMPL3UZ)

• Drug Name: 1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one
• Synonyms: CHEMBL174048; 1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one; SCHEMBL3196395; BDBM50157127; (Z)-1-(5-Furan-2-yl-oxazol-2-yl)-octadec-9-en-1-one

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 2:
  Molecular Weight (mw); 399.6
  Logarithm of the Partition Coefficient (xlogp); 8.6
  Rotatable Bond Count (rotbonds); 17
  Hydrogen Bond Donor Count (hbonddonor); 0
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C25H37NO3
  IUPAC Name: (Z)-1-[5-(furan-2-yl)-1,3-oxazol-2-yl]octadec-9-en-1-one
  Canonical SMILES: CCCCCCCC/C=C\\CCCCCCCC(=O)C1=NC=C(O1)C2=CC=CO2
  InChI: InChI=1S/C25H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-22(27)25-26-21-24(29-25)23-19-17-20-28-23/h9-10,17,19-21H,2-8,11-16,18H2,1H3/b10-9-
  InChIKey: RZGSPAWMLKONHZ-KTKRTIGZSA-N
• Cross-matching ID:
  PubChem CID: 11361560
  TTD ID: D0I8BO

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403.